Long-term changes in the antinociceptive potency of morphine or dexmedetomidine after a single treatment

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Acute tolerance develops after a single administration of opiate or α2-adrenergic agonists, but the characteristics of the delayed type of acute tolerance have not been analyzed in acute and inflammatory thermal pain tests. We investigated the long-term changes in the antinociceptive potency of morphine (10 mg/kg) injected intraperitoneally and the α2-adrenoceptor agonist dexmedetomidine (150 μg/kg intraperitoneally) on acute heat pain (tail-flick test) sensitivity and on carrageenan-induced inflammatory thermal hyperalgesia (paw withdrawal test) after a second injection 7 days later. The first treatment did not influence the baseline values on Day 8 in either test. In the tail-flick test, the antinociceptive potency of morphine, but not that of dexmedetomidine, was significantly decreased after repeated administration, suggesting a delayed type of acute tolerance to morphine. In contrast, the antihyperalgesic effect of morphine in the paw withdrawal test did not change after repeated injection, whereas the potency of dexmedetomidine was increased on Day 8. There were significant differences between the inflamed and non-inflamed sides on Day 1 but not on Day 8, revealing an increased potency of the drugs on the inflamed side. There was no sign of cross-tolerance between the two drugs in either pain test. These data indicate long-term changes in the antinociceptive potency of morphine or dexmedetomidine after single treatment in different heat pain tests.

Original languageEnglish
Pages (from-to)812-818
Number of pages7
JournalAnesthesia and Analgesia
Volume101
Issue number3
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Dexmedetomidine
Morphine
Hot Temperature
Pain
Opiate Alkaloids
Therapeutics
Adrenergic Agonists
Injections
Carrageenan
Hyperalgesia
Acute Pain
Pharmaceutical Preparations
Adrenergic Receptors

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

@article{a62eb06a099e4dd1b72683a77baa361e,
title = "Long-term changes in the antinociceptive potency of morphine or dexmedetomidine after a single treatment",
abstract = "Acute tolerance develops after a single administration of opiate or α2-adrenergic agonists, but the characteristics of the delayed type of acute tolerance have not been analyzed in acute and inflammatory thermal pain tests. We investigated the long-term changes in the antinociceptive potency of morphine (10 mg/kg) injected intraperitoneally and the α2-adrenoceptor agonist dexmedetomidine (150 μg/kg intraperitoneally) on acute heat pain (tail-flick test) sensitivity and on carrageenan-induced inflammatory thermal hyperalgesia (paw withdrawal test) after a second injection 7 days later. The first treatment did not influence the baseline values on Day 8 in either test. In the tail-flick test, the antinociceptive potency of morphine, but not that of dexmedetomidine, was significantly decreased after repeated administration, suggesting a delayed type of acute tolerance to morphine. In contrast, the antihyperalgesic effect of morphine in the paw withdrawal test did not change after repeated injection, whereas the potency of dexmedetomidine was increased on Day 8. There were significant differences between the inflamed and non-inflamed sides on Day 1 but not on Day 8, revealing an increased potency of the drugs on the inflamed side. There was no sign of cross-tolerance between the two drugs in either pain test. These data indicate long-term changes in the antinociceptive potency of morphine or dexmedetomidine after single treatment in different heat pain tests.",
author = "Gyongyi Horvath and Gabriella Kekesi and Ildiko Dobos and Walter Klimscha and Gyorgy Benedek",
year = "2005",
month = "9",
doi = "10.1213/01.ane.0000166982.19796.ae",
language = "English",
volume = "101",
pages = "812--818",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Long-term changes in the antinociceptive potency of morphine or dexmedetomidine after a single treatment

AU - Horvath, Gyongyi

AU - Kekesi, Gabriella

AU - Dobos, Ildiko

AU - Klimscha, Walter

AU - Benedek, Gyorgy

PY - 2005/9

Y1 - 2005/9

N2 - Acute tolerance develops after a single administration of opiate or α2-adrenergic agonists, but the characteristics of the delayed type of acute tolerance have not been analyzed in acute and inflammatory thermal pain tests. We investigated the long-term changes in the antinociceptive potency of morphine (10 mg/kg) injected intraperitoneally and the α2-adrenoceptor agonist dexmedetomidine (150 μg/kg intraperitoneally) on acute heat pain (tail-flick test) sensitivity and on carrageenan-induced inflammatory thermal hyperalgesia (paw withdrawal test) after a second injection 7 days later. The first treatment did not influence the baseline values on Day 8 in either test. In the tail-flick test, the antinociceptive potency of morphine, but not that of dexmedetomidine, was significantly decreased after repeated administration, suggesting a delayed type of acute tolerance to morphine. In contrast, the antihyperalgesic effect of morphine in the paw withdrawal test did not change after repeated injection, whereas the potency of dexmedetomidine was increased on Day 8. There were significant differences between the inflamed and non-inflamed sides on Day 1 but not on Day 8, revealing an increased potency of the drugs on the inflamed side. There was no sign of cross-tolerance between the two drugs in either pain test. These data indicate long-term changes in the antinociceptive potency of morphine or dexmedetomidine after single treatment in different heat pain tests.

AB - Acute tolerance develops after a single administration of opiate or α2-adrenergic agonists, but the characteristics of the delayed type of acute tolerance have not been analyzed in acute and inflammatory thermal pain tests. We investigated the long-term changes in the antinociceptive potency of morphine (10 mg/kg) injected intraperitoneally and the α2-adrenoceptor agonist dexmedetomidine (150 μg/kg intraperitoneally) on acute heat pain (tail-flick test) sensitivity and on carrageenan-induced inflammatory thermal hyperalgesia (paw withdrawal test) after a second injection 7 days later. The first treatment did not influence the baseline values on Day 8 in either test. In the tail-flick test, the antinociceptive potency of morphine, but not that of dexmedetomidine, was significantly decreased after repeated administration, suggesting a delayed type of acute tolerance to morphine. In contrast, the antihyperalgesic effect of morphine in the paw withdrawal test did not change after repeated injection, whereas the potency of dexmedetomidine was increased on Day 8. There were significant differences between the inflamed and non-inflamed sides on Day 1 but not on Day 8, revealing an increased potency of the drugs on the inflamed side. There was no sign of cross-tolerance between the two drugs in either pain test. These data indicate long-term changes in the antinociceptive potency of morphine or dexmedetomidine after single treatment in different heat pain tests.

UR - http://www.scopus.com/inward/record.url?scp=23944433437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944433437&partnerID=8YFLogxK

U2 - 10.1213/01.ane.0000166982.19796.ae

DO - 10.1213/01.ane.0000166982.19796.ae

M3 - Article

C2 - 16115996

AN - SCOPUS:23944433437

VL - 101

SP - 812

EP - 818

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 3

ER -